Amoy Diagnostics Co., Ltd. (SHE:300685)
16.52
-0.97 (-5.55%)
Nov 20, 2026, 3:04 PM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 6.29 billion as of November 20, 2026. It is the 9,841st most valuable company in the world and the 2,102nd biggest in China. Its market cap has decreased by 27.37% in one year.
Market Cap
6.29B
Enterprise Value
5.20B
Revenue
1.20B
Global Rank
Country Rank
#2,102 China
PE Ratio
19.19
ChartMarket Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 6.29B, an increase of 294.16%. That is a compound annual growth rate of 15.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 6.29B | -20.48% |
| Dec 31, 2025 | 7.92B | -11.84% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BGI Genomics | 13.20B |
| Guangzhou Kingmed Diagnostics Group | 12.10B |
| Dian Diagnostics Group | 11.21B |
| Beijing Strong Biotechnologies,Inc. | 7.43B |
| Shanghai Runda Medical Technology | 4.78B |
| Cowealth Medical China | 3.83B |
| Shanghai Labway Clinical Laboratory | 3.39B |
| Medicalsystem Biotechnology | 3.38B |